- Home
- POCI vs SNTI Comparison
POCI vs SNTI Comparison
Compare POCI & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- SNTI
- Stock Information
- Founded
- POCI 1982
- SNTI 2016
- Country
- POCI United States
- SNTI United States
- Employees
- POCI N/A
- SNTI N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- POCI Health Care
- SNTI Health Care
- Exchange
- POCI Nasdaq
- SNTI Nasdaq
- Market Cap
- POCI 35.1M
- SNTI 39.6M
- IPO Year
- POCI N/A
- SNTI N/A
- Fundamental
- Price
- POCI $4.50
- SNTI $1.35
- Analyst Decision
- POCI
- SNTI Strong Buy
- Analyst Count
- POCI 0
- SNTI 2
- Target Price
- POCI N/A
- SNTI $8.50
- AVG Volume (30 Days)
- POCI 3.4K
- SNTI 136.3K
- Earning Date
- POCI 09-29-2025
- SNTI 08-07-2025
- Dividend Yield
- POCI N/A
- SNTI N/A
- EPS Growth
- POCI N/A
- SNTI N/A
- EPS
- POCI N/A
- SNTI N/A
- Revenue
- POCI $17,626,155.00
- SNTI N/A
- Revenue This Year
- POCI N/A
- SNTI N/A
- Revenue Next Year
- POCI N/A
- SNTI $150.00
- P/E Ratio
- POCI N/A
- SNTI N/A
- Revenue Growth
- POCI N/A
- SNTI N/A
- 52 Week Low
- POCI $3.47
- SNTI $1.31
- 52 Week High
- POCI $6.59
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- POCI 40.34
- SNTI 27.94
- Support Level
- POCI $4.30
- SNTI $1.38
- Resistance Level
- POCI $5.05
- SNTI $1.47
- Average True Range (ATR)
- POCI 0.13
- SNTI 0.09
- MACD
- POCI -0.04
- SNTI 0.00
- Stochastic Oscillator
- POCI 26.67
- SNTI 10.29
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.